A live attenuated human metapneumovirus vaccine strain provides complete protection against homologous viral infection and cross-protection against heterologous viral infection in BALB/c mice

Clinical and Vaccine Immunology

Volumn 20, Issue 8, 2013, Pages 1246-1254

  Liu, Ping ^a   Shu, Zhou ^a   Qin, Xian ^a   Dou, Ying ^a   Zhao, Yao ^a   Zhao, Xiaodong ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN METAPNEUMOVIRUS VACCINE; LIVE VACCINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; EXPERIMENTAL MOUSE; FEMALE; GENE DOSAGE; GENE IDENTIFICATION; GENE LOCATION; GLYCOSYLATION; HUMAN METAPNEUMOVIRUS; HUMAN METAPNEUMOVIRUS INFECTION; IMMUNIZATION; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA GENE; VIRUS DETECTION; VIRUS GENOME; VIRUS NEUTRALIZATION; VIRUS STRAIN; WILD TYPE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CROSS PROTECTION; DISEASE MODELS, ANIMAL; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; METAPNEUMOVIRUS; MICE; MICE, INBRED BALB C; MICROSCOPY; PARAMYXOVIRIDAE INFECTIONS; TIME FACTORS; VACCINES, ATTENUATED; VIRAL LOAD; VIRAL VACCINES;

EID: 84880879773     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00145-13     Document Type: Article

References (41)

1. Van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, Osterhaus AD. 2001. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 7:719-724.
2. Boivin G, Mackay I, Sloots TP, Madhi S, Freymuth F, Wolf D, Shemer- Avni Y, Ludewick H, Gray GC, LeBlanc E. 2004. Global genetic diversity of human metapneumovirus fusion gene. Emerg. Infect. Dis. 10:1154- 1157.
3. Galiano M, Videla C, Puch SS, Martínez A, Echavarría M, Carballal GE. 2004. Evidence of human metapneumovirus in children in Argentina. Med. Virol. 72:299-303.
4. Herfst S, M de Graaf Schrauwen EJ, Ulbrandt ND, Barnes AS, Senthil K, Osterhaus AD, Fouchier RA, van den Hoogen BG. 2007. Immunization of Syrian golden hamsters with F subunit vaccine of human metapneumovirus induces protection against challenge with homologous or heterologous strains. J. Gen. Virol. 88:2702-2709.
5. Herfst S, Schrauwen E, de Graaf M, van Amerongen G, van den Hoogen BG, de Swart RL, Osterhaus AD, Fouchier RA. 2008. Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques. Vaccine 26:4224-4230.
6. van den Hoogen BG, Herfst S, Sprong L, Cane PA, Forleo E. 2004. Antigenic and genetic variability of human metapneumoviruses. Emerg. Infect. Dis. 10:658-666.
7. Herfst S, Fouchier RA. 2008. Vaccination approaches to combat human metapneumovirus lower respiratory tract infections. J. Clin. Virol. 41:49 -52.
8. Biacchesi S, Pham QN, Skiadopoulos MH, Murphy BR, Collins PL, Buchholz UJ. 2005. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J. Virol. 79:12608-12613.
9. Herfst S, de Graaf M, EJ Schrauwen, Sprong L, Hussain K, BG Van den Hoogen, Osterhaus AD, Fouchier RA. 2008. Generation of temperaturesensitive human metapneumovirus strains that provide protective immunity in hamsters. J. Gen. Virol. 89:1553-1562.
10. Pham QN, Biacchesi S, Skiadopoulos MH, Murphy BR, Collins PL, Buchholz UJ. 2005. Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo. J. Virol. 79:15114-15122.
11. Tang RS, Mahmood K, Macphail M, Guzzetta JM, Haller AA, Liu H, Kaur J, Stillman EA, Schickli JH, Fouchier RA, Osterhaus AD, Spaete RR. 2005. A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys. Vaccine 23:1657-1667.
12. Cseke G, Wright DW, Tollefson SJ, Johnson JE, Crowe JE, Williams JV. 2007. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J. Virol. 81:698-707.
13. Herd KA, Mahalingam S, Mackay IM, Nissen M, Sloots TP, Tindle RW. 2006. Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. J. Virol. 80:2034- 2044.
14. Hamelin ME, Couture C, Sackett MK, Boivin G. 2007. Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virus. J. Gen. Virol. 88:3391-3400.
15. De Swart RL, van den Hoogen BG, Kuiken T, Herfst S, van Amerongen G, Yuksel S. 2007. Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection. Vaccine 25:8518-8528.
16. Yim KC, Cragin RP, Boukhvalova MS, Blanco JC, Hamlin ME, Boivin G, Porter DD, Prince GA. 2007. Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged. Vaccine 25:5034-5040.
17. De Swart RL, Kuiken T, Timmerman HH, van Amerongen G, Van Den Hoogen BG, Vos HW, Neijens HJ, Andeweg AC, Osterhaus AD. 2002. Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection. J. Virol. 76:11561-11569.
18. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, Parrott RH. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
19. Zhang J, Dou Y, Wu J, She W, Luo L, Zhao Y, Liu P, Zhao X. 2011. Effects of N-linked glycosylation of the fusion protein on replication capacity of human metapneumovirus in vitro and in mouse lungs. J. Gen. Virol. 92:1666-1675.
20. Peret TC, Boivin G, Li Y, Couillard M, Humphrey C, Osterhaus AD, Erdman DD, Anderson LJ. 2002. Characterization of human metapneumoviruses isolated from patients in North America. J. Infect. Dis. 185: 1660-1663.
21. Maertzdorf J, Wang CK, Brown JB, Quinto JD, Chu M, de Graaf M, van den Hoogen BG, Spaete R, Osterhaus AD, Fouchier RA. 2004. Real-time reverse transcriptase PCR assay for detection of human metapneumovirus from all known genetic lineages. J. Clin. Microbiol. 42:981-986.
22. van den Hoogen BG, Herfst S, de Graaf M Sprong L, van Lavieren R, van Amerongen G, Yüksel S, Fouchier RA, Osterhaus AD, de Swart RL. 2007. Experimental infection of macaques with human metapneumovirus induces transient protective immunity. J. Gen. Virol. 88:1251-1259.
23. Chen X, Zhang Z, Zhao Y, Liu E, Zhao X. 2010. Acute lower respiratory tract infections by human metapneumovirus in children in Southwest China: a 2-year study. Pediatr. Pulmonol. 45:824-831.
24. Falsey AR, Formica MA, Walsh EE. 2009. Microneutralization assay for the measurement of neutralizing antibodies to human metapneumovirus. J. Clin. Virol. 46:314-317.
25. Ebihara T, Endo R, Ma X, Ishiguro N, Kikuta H. 2005. Detection of human metapneumovirus antigens in nasopharyngeal secretions by an immunofluorescent antibody test. J. Clin. Microbiol. 43:1138-1141.
26. Cimolai N, Taylor G, Mah D, Morrison B. 1992. Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microbiol. Immunol. 36: 465-478.
27. Schickli JH, Kaur J, Ulbrandt N, Spaete RR, Tang RS. 2005. An S101P substitution in the putative cleavage motif of the human metapneumovirus fusion protein is a major determinant for trypsin-independent growth in Vero cells and does not alter tissue tropism in hamsters. J. Virol. 79: 10678-10689.
28. Biacchesi S, Pham QN, Skiadopoulos MH, Murphy BR, Collins PL, Buchholz UJ. 2006. Modification of the trypsin-dependent cleavage activation site of the human metapneumovirus fusion protein to be trypsin independent does not increase replication or spread in rodents or nonhuman primates. J. Virol. 80:5798-5806.
29. Spriggs MK, Olmsted RA, Venkatesan S, Coligan JE, Collins PL. 1986. Fusion glycoprotein of human parainfluenza virus type 3: nucleotide sequence of the gene, direct identification of the cleavage activation site, and comparison with other paramyxoviruses. Virology 152:241-251.
30. Poch O, Blumberg BM, Bougueleret L, Tordo N. 1990. Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains. J. Gen. Virol. 71:1153-1162.
31. Poch O, Sauvaget I, Delarue M, Tordo N. 1989. Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J. 8:3867-3874.
32. Martinello RA, Esper F, Weibel C, Ferguson D, Landry ML, Kahn JS. 2006. Human metapneumovirus and exacerbations of chronic obstructive pulmonary disease. J. Infect. 53:248-254.
33. Mullins JA, Erdman DD, Weinberg GA, Edwards K, Hall CB, Walker FJ, Iwane M, Anderson LJ. 2004. Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg. Infect. Dis. 10:700-705.
34. Vicente D, Montes M, Cilla G, Perez Trallero E. 2004. Human metapneumovirus and chronic obstructive pulmonary disease. Emerg. Infect. Dis. 10:1338-1339.
35. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, Wright PF, Crowe JE Jr. 2004. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N. Engl. J. Med. 350:443-450.
36. Williams JV, Wang CK, Yang CF, Tollefson SJ, House FS, Eck JM, Chu M, Brown JB, Lintao LD, Quinto JD, Chu D, Spaete RR, Edwards KM, Wright PF, Crowe JE Jr. 2006. The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience. J. Infect. Dis. 193:387-395.
37. De Graaf M, Herfst S, Schrauwen E, van Amerongen G, Osterhaus AD, Fouchier RA. 2009. Fusion protein is the main determinant of metapneumovirus host tropism. J. Gen. Virol. 90:1408-1416.
38. Boivin G, Abed Y, Pelletier G, Ruel L, Moisan D, Côté S, Peret TC, Erdman DD, Anderson LJ. 2002. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J. Infect. Dis. 186:1330-1334.
39. Skiadopoulos MH, Biacchesi S, Buchholz UJ, Riggs JM, Surman SR, Amaro-Carambot E, McAuliffe JM, Elkins WR, St Claire M, Collins PL, Murphy BR. 2004. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J. Virol. 78:6927-6937.
40. Williams JV, Chen Z, Cseke G, Wright DW, Keefer CJ, Hessell SJA, Podsiad A, Shepherd BE. 2007. A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo. J. Virol. 81:8315-8324.
41. Williams JV, Tollefson SJ, Johnson JE, Crowe JE Jr. 2005. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity. J. Virol. 79:10944-10951.